Kathleen Larrimer Beckmann
Geen lopende functies
Loopbaan van Kathleen Larrimer Beckmann
Eerdere bekende functies van Kathleen Larrimer Beckmann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Financieel Directeur/CFO | - | - |
Opleiding van Kathleen Larrimer Beckmann
| Stanford Graduate School of Business | Masters Business Admin |
| Princeton University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |
